Leukemia· 2022Q1· Review

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms

Joseph D. Khoury, Éric Solary, Oussama Abla, Yassmine Akkari et al.

3,967citations
Q1SCImago
2022year

Short summary

The 5th edition of the WHO Classification of Haematolymphoid Tumours refines diagnostic criteria for myeloid and histiocytic/dendritic neoplasms, emphasizing therapeutically actionable biomarkers and molecular biology.

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app

Key pointsIn the app

Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Get it on Google Play Download on the App Store

Field: Hematology

HematologyMedicine